90 related articles for article (PubMed ID: 10723769)
1. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
Möller T; Korsatko W
Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
[TBL] [Abstract][Full Text] [Related]
2. ["Non-solvent shock agglomeration technology" as a new alternative method for work on ibuprofen. 4. Production and evaluation of quick release forms].
Möller T; Korsatko W
Pharmazie; 2000 Jan; 55(1):53-8. PubMed ID: 10683872
[TBL] [Abstract][Full Text] [Related]
3. ["Non-solvent shock agglomeration"--the technology of a new alternative method for determination of ibuprofen. 6. Stability of s(+)-ibuprofen].
Möller T; Korsatko W
Pharmazie; 2000 Jun; 55(6):449-53. PubMed ID: 10907254
[TBL] [Abstract][Full Text] [Related]
4. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
5. Stereospecific formulation and characterization of sustained release ibuprofen microspheres.
Janjikhel RK; Adeyeye CM
J Microencapsul; 1997; 14(4):409-26. PubMed ID: 9229341
[TBL] [Abstract][Full Text] [Related]
6. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
[TBL] [Abstract][Full Text] [Related]
7. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of Ibuprofen.
Tamilvanan S; Sa B
AAPS PharmSciTech; 2006 Sep; 7(3):72. PubMed ID: 17025252
[TBL] [Abstract][Full Text] [Related]
11. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates.
Nerurkar J; Jun HW; Price JC; Park MO
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):56-68. PubMed ID: 15893919
[TBL] [Abstract][Full Text] [Related]
12. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
13. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
14. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
Abioye AO; Kola-Mustapha A
Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
[TBL] [Abstract][Full Text] [Related]
15. Dissolution studies on tablets of ibuprofen using chitosan.
Ilango R; Kavimani S; Jaykar B; Umamaheshwari G
Indian J Exp Biol; 1999 May; 37(5):505-8. PubMed ID: 10492622
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and optimization of Ibuprofen tablets by direct compression method.
Bushra R; Shoaib MH; Aslam N; Hashmat D; Ur-Rehman M
Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
[TBL] [Abstract][Full Text] [Related]
17. Introduction of β-cyclodextrin into poly(aspartic acid) matrix for adsorption and time-release of ibuprofen.
Sun ZY; Shen MX; Yang AW; Liang CQ; Wang N; Cao GP
Chem Commun (Camb); 2011 Jan; 47(3):1072-4. PubMed ID: 21079853
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of a novel conjugate of ibuprofen with 3-hydroxybutyric acid oligomers.
Stasiak P; Ehrhardt C; Juzwa M; Sznitowska M
J Pharm Pharmacol; 2009 Aug; 61(8):1119-24. PubMed ID: 19703357
[TBL] [Abstract][Full Text] [Related]
19. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
[TBL] [Abstract][Full Text] [Related]
20. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
